Business

H.C. Wainwright Reiterates Buy Rating on IO Biotech, Keeps PT at $14

Aug 26, 2025 - 14:00
 0
H.C. Wainwright Reiterates Buy Rating on IO Biotech, Keeps PT at $14
Read More

Related Posts

DOGE says IRS modernization program is $15B over budget and 30 years overdue

DOGE says IRS modernization program is $15B over budget...

Mar 21, 2025  2

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

Mar 21, 2025  0

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025  4

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025  0

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025  2

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corp...

Mar 21, 2025  0